Type 2 diabetes mellitus' impact on heart failure patients' exercise tolerance: a focus on maximal fat oxidation during exercise.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Frontiers in Cardiovascular Medicine Pub Date : 2025-02-10 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1485755
Huiying Zhu, Jianchao Pan, Jianxuan Wen, Xiaojing Dang, Xiankun Chen, Yunxiang Fan, Weihui Lu, Wei Jiang
{"title":"Type 2 diabetes mellitus' impact on heart failure patients' exercise tolerance: a focus on maximal fat oxidation during exercise.","authors":"Huiying Zhu, Jianchao Pan, Jianxuan Wen, Xiaojing Dang, Xiankun Chen, Yunxiang Fan, Weihui Lu, Wei Jiang","doi":"10.3389/fcvm.2025.1485755","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the impact of type 2 diabetes mellitus (T2DM) on exercise tolerance and fat oxidation capacity in patients with heart failure (HF).</p><p><strong>Methods: </strong>We retrospectively analyzed 108 Chinese patients with HF who were divided into a diabetic group (T2DM group, <i>n</i> = 47) and a non-diabetic group (non-T2DM group, <i>n</i> = 61). All subjects completed cardiopulmonary exercise testing (CPX). We determined their fat oxidation (FATox) by indirect calorimetry.</p><p><strong>Results: </strong>In the HF patients, the peak oxygen uptake (VO<sub>2</sub>) value was 14.76 ± 3.27 ml/kg/min in the T2DM group and 17.76 ± 4.64 ml/kg/min in the non-T2DM group. After adjusting for age, sex, body mass index (BMI), log N-terminal pro-B type natriuretic peptide (log NT-proBNP), left ventricular ejection fraction (LVEF), hemoglobin, renal function, coronary heart disease and hypertension, the peak VO<sub>2</sub> was lower in the T2DM group compared to the non-T2DM group with a mean difference (MD) of -2.0 ml/kg/min [95% confidence interval (CI), -3.18 to -0.82, <i>P</i> < 0.01]. The VO<sub>2</sub> at anaerobic threshold (AT VO<sub>2</sub>) was also lower in the T2DM group than in the non-T2DM group, with a MD of -1.11 ml/kg/min (95% CI -2.04 to -0.18, <i>P</i> < 0.05). Regarding the fat oxidation capacity during CPX, the T2DM group's maximal fat oxidation (MFO) was lower than that of the non-T2DM group (0.143 ± 0.055 vs. 0.169 ± 0.061 g/min, <i>P</i> < 0.05). In addition, the T2DM group had lower FATox at exercise intensity levels of 40% (<i>P</i> < 0.05) and 50% (<i>P</i> < 0.05) of peak VO<sub>2</sub>, compared to the non-T2DM group.</p><p><strong>Conclusions: </strong>T2DM is associated with a decrease in exercise tolerance and fat oxidation capacity in patients with heart failure. Thus, it could be useful to develop exercises of appropriate intensity to optimize physical and metabolic health.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1485755"},"PeriodicalIF":2.8000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11847838/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1485755","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the impact of type 2 diabetes mellitus (T2DM) on exercise tolerance and fat oxidation capacity in patients with heart failure (HF).

Methods: We retrospectively analyzed 108 Chinese patients with HF who were divided into a diabetic group (T2DM group, n = 47) and a non-diabetic group (non-T2DM group, n = 61). All subjects completed cardiopulmonary exercise testing (CPX). We determined their fat oxidation (FATox) by indirect calorimetry.

Results: In the HF patients, the peak oxygen uptake (VO2) value was 14.76 ± 3.27 ml/kg/min in the T2DM group and 17.76 ± 4.64 ml/kg/min in the non-T2DM group. After adjusting for age, sex, body mass index (BMI), log N-terminal pro-B type natriuretic peptide (log NT-proBNP), left ventricular ejection fraction (LVEF), hemoglobin, renal function, coronary heart disease and hypertension, the peak VO2 was lower in the T2DM group compared to the non-T2DM group with a mean difference (MD) of -2.0 ml/kg/min [95% confidence interval (CI), -3.18 to -0.82, P < 0.01]. The VO2 at anaerobic threshold (AT VO2) was also lower in the T2DM group than in the non-T2DM group, with a MD of -1.11 ml/kg/min (95% CI -2.04 to -0.18, P < 0.05). Regarding the fat oxidation capacity during CPX, the T2DM group's maximal fat oxidation (MFO) was lower than that of the non-T2DM group (0.143 ± 0.055 vs. 0.169 ± 0.061 g/min, P < 0.05). In addition, the T2DM group had lower FATox at exercise intensity levels of 40% (P < 0.05) and 50% (P < 0.05) of peak VO2, compared to the non-T2DM group.

Conclusions: T2DM is associated with a decrease in exercise tolerance and fat oxidation capacity in patients with heart failure. Thus, it could be useful to develop exercises of appropriate intensity to optimize physical and metabolic health.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2型糖尿病对心力衰竭患者运动耐量的影响:运动中最大脂肪氧化的研究
目的:探讨2型糖尿病(T2DM)对心力衰竭(HF)患者运动耐量和脂肪氧化能力的影响。方法:回顾性分析108例中国HF患者,分为糖尿病组(T2DM组,n = 47)和非糖尿病组(非T2DM组,n = 61)。所有受试者均完成心肺运动试验(CPX)。我们用间接量热法测定了它们的脂肪氧化(FATox)。结果:HF患者T2DM组VO2峰值为14.76±3.27 ml/kg/min,非T2DM组VO2峰值为17.76±4.64 ml/kg/min。在调整年龄、性别、体重指数(BMI)、log n-末端前b型利钠肽(log NT-proBNP)、左心室射血分数(LVEF)、血红蛋白、肾功能、冠心病和高血压等因素后,T2DM组VO2峰值低于非T2DM组,平均差值(MD)为-2.0 ml/kg/min[95%可信区间(CI), -3.18 ~ -0.82,无氧阈值(at VO2)也低于非T2DM组。与非t2dm组相比,MD为-1.11 ml/kg/min (95% CI为-2.04 ~ -0.18,P P P P 2)。结论:T2DM与心力衰竭患者运动耐量和脂肪氧化能力下降有关。因此,开发适当强度的运动以优化身体和代谢健康可能是有用的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
期刊最新文献
Cardiac surgery in an infant hemophilia B carrier with moderate hemophilia: a case report. Case Report: A case of giant left ventricular aneurysm resulting in LAD compression and stenosis. Cardiovascular complications in chronic active Epstein-Barr virus infection: a narrative review. Global burden and trend of ischemic heart disease and its attributable risk factors among women of childbearing age from 1990 to 2021. Prevalence and characterization of heart failure in Aragon, Spain (ICAR study).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1